Is it a business for the cardiac surgeon?

Similar documents
Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Developments in Valve Surgery

Indication, Timing, Assessment and Update on TAVI

Policy Specific Section: March 30, 2012 March 7, 2013

Alternate Vascular Access for TAVR. Gian Paolo Ussia Campus Bio-medico University, Rome Italy

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

AVR with Sutureless Valves State of the Art

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts

TAVR IN INTERMEDIATE-RISK PATIENTS

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel

TAVR in Intermediate Risk Populations /Optimizing Systems for TAVR

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

Aortic Stenosis: Interventional Choice for a 70-year old- SAVR, TAVR or BAV? Interventional Choice for a 90-year old- SAVR, TAVR or BAV?

TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con

Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial

How to Avoid Prosthesis-Patient Mismatch

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

Update on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center

TAVI Versus Suturless Valve In Intermediate Risk Patients

TAVR: Intermediate Risk Patients

Role of Sutureless Valves in the Surgeon s Armamentarium Prof. Dr Malakh Shrestha Vice Chair, Director of Aortic Surgery Cardiothoracic,

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Transcatheter Valve Replacement: Current State in 2017

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

Severe Aortic Valve Disease: TAVR in Four Ages and Four Etiologies Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

IPAC date: May of 13

Transcatheter Aortic Valve Implantation (TAVI) Overview for Wales. Dr Richard Anderson University Hospital of Wales, Cardiff, UK

TAVR SPRING 2017 The evolution of TAVR

TAVI limitations for low risk patients

Evolving and Expanding Indications for TAVR

Edwards Sapien. Medtronic CoreValve. Inoperable FDA approved High risk: in trials. FDA approved

Aortic Stenosis: Background

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

TAVR and Cardiac Surgeons

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Transcatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40

Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

The Future of Medicine. Who to TAVR? Azeem Latib MD EMO-GVM Centro Cuore Columbus and San Raffaele Scientific Institute, Milan, Italy

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD

Aortic Stenosis: Open vs TAVR vs Nothing

L evoluzione nel management della valvulopatia aortica

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Surgeon Involvement in Transcatheter Valve Therapy

Le TAVI pour tout le monde?

TAVR for low-risk patients in 2017: not so fast.

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

The Heart Team and the minimalist approach to TAVR today Is there a conflict? G T Stavridis MD FETCS Onassis Cardiac Surgery Ctr.

Re-do aortic valve replacement after previous homograft aortic root replacement

Transcatheter Aortic Valve Replacement TAVR

State of the Art and Future perspective

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

What is TAVR? Transcatheter Aortic Valve Replacement

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update

Interventional procedures guidance Published: 26 July 2017 nice.org.uk/guidance/ipg586

A new option for the Diagnosis and Management of Valvular Heart Disease. Oregon Comprehensive Valve Center

ACCESS TO ALL APPROPRIATE TREATMENTS FOR ALL HEART VALVE DISEASE PATIENTS

The SAPIEN 3 TAVI Advantage

TAVI After PARTNER-2 : The Hamilton Approach

Transcatheter Aortic Valve Replacement

The Role of TAVI in high-risk and normal-risk Patients

What is TAVR? Transcatheter Aortic Valve Replacement

7 th Conference of Transcatheter Heart Valve Therapies

Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis

TAVR for Complex Aortic Valvular Conditions

For the SURTAVI Investigators

Valvular Intervention

1-YEAR OUTCOMES FROM JOHN WEBB, MD

Minimally invasive aortic valve surgery: new solutions to old problems.

PERCUTANEOUS STRUCTURAL UPDATES TAVR WATCHMAN(LEFT ATRIAL APPENDAGE OCCLUDERS) MITRACLIP PARAVALVULAR LEAK REPAIRS ASD/PFO CLOSURES VALVULOPLASTIES

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

LOW RISK TAVR. WHAT THE FUTURE HOLDS

Aortic Stenosis and TAVR TARUN NAGRANI, MD INTERVENTIONAL AND ENDOVASCULAR CARDIOLOGIST, SOMC

Neal Kleiman, MD Houston Methodist DeBakey Heart and Vascular Institute

Less Invasive Aortic Valve Surgery

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Aortic Stenosis Steven F. Bolling, M.D. Professor of Cardiac Surgery University of Michigan

Appropriate Use of TAVR - now and in the future. A Surgeon s Perspective. Neil Moat Royal Brompton Hospital, London, UK

TAVI: Nouveaux Horizons

Riflessioni sui risultati prodotti, sviluppi futuri e nuove proposte

TAVR Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory. Cleveland Clinic.

Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)

TAVI, TMVI, TEVAR, EVAR: The end of standard Cardiovascular Surgery? Perspectives of a Cardiac Surgeon

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

Accepted Manuscript. Sixteen Years Later and the Debate for TAVR or SAVR Remains Controversial. Saina Attaran, MD, Vinod H.

8. Nov, 2018 Athens Clossroad 2018, Athens GREEK

Transcatheter Heart Valve Procedures

TAVI: Transapical Procedures

Transcatheter Aortic Valve Implantation (TAVI)

Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.

TAVR or SAVR A glimpse into the future

Are Heart Valve Referral Centers Feasible in Latin America?

Transcatheter aortic valve implantation for aortic stenosis

TAVR in 2020: What is Next!!!!

THE VALVE CLINIC VALVE CONFERENCE

Transcription:

TAVI FOR LOW RISK PATIENTS Is it a business for the cardiac surgeon? Augusto D Onofrio Gino Gerosa Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy

T A V I

Cardiac surgery evolution Beating heart commissurotomy Conventional AVR Minimally invasive AVR Sutureless/Rapid deployment AVR Valve repair TAVI Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon?

= EMODINAMISTA CCH

Why? Does the cardiac surgeon performing TF-TAVI need to be able to perform emergency PCI and treat peripheral complications using catheters BUT The interventional cardiologist performing TF-TAVI doesn t need to be able to establish emergency CPB and perform (at least) median sternotomy?

Surgeons 7/16

Surgeons 3/25

Surgeons 0/104

e l HEART TEAM???

Cardiac surgeons who perform transcatheter aortic valve replacement (TAVR) regularly participated in all aspects of intraoperative procedure, except operating imaging equipment.

Surgeon s armamentarium (1)

Surgeon s armamentarium (2)

Interventional cardiologist s armamentarium

I STILL BELIEVE IN THE HEART TEAM

TAVI FOR LOW RISK PATIENTS IT MUST BE a business also surgeon!!! for the cardiac Augusto D Onofrio Gino Gerosa Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Italy

Indications for CABG (According to guidelines) CABG recommended in 53% PCI recommended in 34% Medical therapy recommended in 12% Indications for PCI (According to guidelines) PCI recommended in 94% CABG recommended in 4% Medical therapy recommended in 2%

Process quality in TAVI No matters who performs TAVI, only results count Analysis of internal results Optimization of the program based on these results Shared decision making with patients and families Unbiased counselling

Complications of TAVI procedures Before a transcatheter approach is raccomended to intermediate-risk patients, some partially issues should be taken into account: - the risk of PPI; - the presence of a bicuspid valve - the need for TAVI in TAVI or PCI after TAVI. The most serious acute complications every operator should be aware of to recognize them in a timely fashion and to set forth the proper management strategy.

Who is the owner of the technique? Cardiac surgeons have been performing IMPLANTATION of prostheses in aortic position with many different APPROACHES: Median sternotomy Ministernotomy Right thoracotomy Since evolving technologies have started to enable to IMPLANT a prosthesis in aortic position through a (simple) transcatheter (transfemoral) APPROACH, cardiac surgeons have been reluctant

OWNERSHIP? Beating heart commissurotomy Conventional AVR Minimally invasive AVR Sutureless/Rapid deployment AVR Valve repair TAVI Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon Cardiac Surgeon Interventional Cardiologist

Technique vs. technology TECHNIQUE (STATIC) The treatment of severe aortic valve stenosis is the IMPLANTATION of a prosthesis in aortic position Conventional prostheses Standard MICS TECHNOLOGY (DYNAMIC) Sutureless/RD prostheses Standard MICS TAVI µics

The cardiac surgeon has to partecipate to: Pre-operative recruitment Planning with the patient the best strategy Intra-operative procedure Perform the procedure in any possible way and approach, changing plans if necessa Post-operative Handling of all the possible complications (ECMO; conversion to full sternotomy, vascular complications

HOTTEST DATA

A Low risk patient implies such a perfect implant of the prosthesis. NO Complication is admitted! SAVR should be mandatory in case of PVL for low risk patient ( whereas mortality rate for Low risk patient SAVr is <1%) The conversion to full sternotomy has to be warranted if the the result is not satisfatictory.

Forest plot for all outcomes in patients with intermediate risk

Is TAVI legitimate in Low risk patients? Reduced compliations impacting survival: AKI; life-threatening bleeding, disabling strokes long term durability? Higher rate of AV block and definitive PM implant 50% 50% Vascular complications Predictable procedure (more than PCI) What about bicuspid valves and concomitant procedures?

Currently major indication is high-risk or inoperable AS TAVI indication is and will be expanded (intermediate/lower risk) Current RCTs for intermediate/low-risk pts are biased & most initiated/funded by industry Physician-initiated RCTs are necessary isolated TAVI vs. savr The TAVI heart-team plays a key role in clinical practice TAVI can be performed with high procedural success rates There is a (substantial) institutional learning curve There are valve-specific complications & limitations Long-term durability data are still rare Will CV surgeons play a key role in TAVI?

What would cardiologists like to be the role of the heart surgeon in the heart team ( as far as guidelines require it )? Confirm decisions they have already taken Confirm indications they have already given Stand-by while they perform procedures

We should implement cardiac surgery training with catheter-based techniques and percutaneous structural heart operations. Whilst our generation will probably be only marginally affected by this ongoing revolution, for our fellows who are about to start their individual practice in the next four or five years this is going to be a big deal. The absence of catheter skills in their training would have detrimental effects, as it would reduce their chances of having an active role in this new era of µics that they strongly deserve for their passion, sacrifices and commitment to the job.

What should ACTUALLY be the role of the heart surgeon in the heart team? Leading role in case discussion Leading role in indications to procedure Leading role in performing transcatheter procedures

Requirements for transcatheter Mitral Valve procedure

Fermamente convinto che la tavi nei low risk sia il futuro Però: PM PVL Sustainability